Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy
Author:
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
https://link.springer.com/content/pdf/10.1007/s11255-021-02997-2.pdf
Reference21 articles.
1. Couser WG (2017) Primary membranous nephropathy. Clin J Am Soc Nephrol 12:983–997. https://doi.org/10.2215/CJN.11761116
2. Radice A, Trezzi B, Maggiore U et al (2016) Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Autoimmun Rev 15:146–154. https://doi.org/10.1016/j.autrev.2015.10.004
3. Dong J, Peng T, Gao J et al (2018) A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis. BMC Immunol 19:18. https://doi.org/10.1186/s12865-018-0254-z
4. Zhang MF, Huang J, Zhang YM et al (2019) Complement activation products in the circulation and urine of primary membranous nephropathy. BMC Nephrol 20:313. https://doi.org/10.1186/s12882-019-1509-5
5. Wen L, Zhao Z, Wang Z et al (2019) High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy. Nephrology (Carlton) 24:703–710. https://doi.org/10.1111/nep.13477
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases;Scientific Reports;2024-08-20
2. Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy;Kidney International;2024-01
3. Membranous nephropathy: Mechanistic insights and therapeutic perspectives;International Immunopharmacology;2023-07
4. Metabolism‐related biomarkers, molecular classification, and immune infiltration in diabetic ulcers with validation;International Wound Journal;2023-05-28
5. The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments;Journal of Medicinal Chemistry;2022-05-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3